FDA.reportPublic FDA data

Avsola 100 MG Injection

RxCUI
2266530
RxNorm name
Avsola 100 MG Injection
Display name
Avsola 100 MG Injection
Full name
Avsola 100 MG Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761086Avsolainfliximab-axxq351(k) BiosimilarRx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
de34bcb7-b524-45c8-9181-61c6f48d540eAvsola 100 MG InjectionSY18These highlights do not include all the information needed to use AVSOLA ® safely and effectively. See full prescribing information for AVSOLA. AVSOLA (infliximab-axxq) for injection, for intravenous use Initial U.S. Approval: 2019 AVSOLA (infliximab-axxq) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwe20250908
de34bcb7-b524-45c8-9181-61c6f48d540eAVSOLA 100 MG InjectionPSN18These highlights do not include all the information needed to use AVSOLA ® safely and effectively. See full prescribing information for AVSOLA. AVSOLA (infliximab-axxq) for injection, for intravenous use Initial U.S. Approval: 2019 AVSOLA (infliximab-axxq) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwe20250908
de34bcb7-b524-45c8-9181-61c6f48d540einfliximab-axxq 100 MG Injection [Avsola]SBD18These highlights do not include all the information needed to use AVSOLA ® safely and effectively. See full prescribing information for AVSOLA. AVSOLA (infliximab-axxq) for injection, for intravenous use Initial U.S. Approval: 2019 AVSOLA (infliximab-axxq) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwe20250908